HLA-DQA1, a member of MHC Class II molecules, its elevated expression has been identified as an adverse indicator for worse prognosis for esophageal squamous cell carcinoma patients [41]. Here, HLA-DQA1 is linked to esophageal squamous cell carcinoma.